Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds
Antioxidants · 28.11.2023 · 12 (12) · 2052
DOI: 10.3390/antiox12122052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 28.11.2023. Verfasst von Anna Rybarczyk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre.
Abstract (Originalsprache)
The development and progression of cancer are associated with the dysregulation of multiple pathways involved in cell proliferation and survival, as well as dysfunction in redox balance, immune response, and inflammation. The master antioxidant pathway, known as the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, regulates the cellular defense against oxidative stress and inflammation, making it a promising cancer prevention and treatment target. Cannabinoids have demonstrated anti-tumor and anti-inflammatory properties, affecting signaling pathways, including Nrf2. Increased oxidative stress following exposure to anti-cancer therapy prompts cancer cells to activate antioxidant mechanisms. This indicates the dual effect of Nrf2 in cancer cells—influencing proliferation and apoptotic processes and protecting against the toxicity of anti-cancer therapy. Therefore, understanding the complex role of cannabinoids in modulating Nrf2 might shed light on its potential implementation as an anti-cancer support. In this review, we aim to highlight the impact of cannabinoids on Nrf2-related factors, with a focus on cancer prevention and treatment. Additionally, we have presented the results of several research studies that combined cannabidiol (CBD) with other compounds targeting Nrf2. Further studies should be directed toward exploring the anti-inflammatory effects of cannabinoids in the context of cancer prevention and therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznań, Poland.
ORCID-Profile: Anna Rybarczyk, Aleksandra Majchrzak-Celińska, Violetta Krajka-Kuźniak
Förderung
- National Science Center
- National Science Centre
Zitieren
APA
Rybarczyk, A., Majchrzak-Celińska, A., & Krajka-Kuźniak, V. (2023). Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds. Antioxidants, 12(12), 2052. https://doi.org/10.3390/antiox12122052
Vancouver
Rybarczyk A, Majchrzak-Celińska A, Krajka-Kuźniak V. Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds. Antioxidants. 2023;12(12):2052. doi:10.3390/antiox12122052
BibTeX
@article{Rybarczyk2023,
author = {Rybarczyk, Anna and Majchrzak-Celińska, Aleksandra and Krajka-Kuźniak, Violetta},
title = {Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {12},
pages = {2052},
doi = {10.3390/antiox12122052}
}
EUVIMED